📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ArQule

1.1 - Company Overview

ArQule Logo

ArQule

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biotechnology research and development of cancer therapeutics, employing its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs, including ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ArQule

Bellwether Bio Logo

Bellwether Bio

HQ: United States Website
  • Description: Provider of novel cell-free DNA-based diagnostic technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bellwether Bio company profile →
Incyclix Bio Logo

Incyclix Bio

HQ: United States Website
  • Description: Provider of small molecule CDK inhibitors for the treatment of advanced and resistant cancers, including INX-315, a selective CDK2 inhibitor in clinical development that targets abnormal cell proliferation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Incyclix Bio company profile →
Imago BioSciences Logo

Imago BioSciences

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical drug development focused on novel medicines for managing proliferative diseases of the bone marrow, translating state-of-the-art science and leveraging the skills and experience of its team and the financial commitment of its investors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imago BioSciences company profile →
Acetylon Logo

Acetylon

HQ: United States Website
  • Description: Provider of small molecule drugs aimed at realizing the therapeutic potential of histone deacetylase; incorporated in 2008 and based in Boston, Massachusetts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acetylon company profile →
Theraclone Sciences Logo

Theraclone Sciences

HQ: United States Website
  • Description: Provider of novel therapeutic antibodies and an antibody discovery platform for infectious diseases and inflammation. Offers a comprehensive screening technology to identify rare human monoclonal antibodies, HIV broadly neutralizing fully human antibodies licensed to Gilead for HIV-cure regimens, and platform technology licensed to OncoResponse for oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theraclone Sciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ArQule

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ArQule

2.2 - Growth funds investing in similar companies to ArQule

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ArQule

4.2 - Public trading comparable groups for ArQule

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ArQule

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ArQule

What does ArQule do?

ArQule is a provider of clinical-stage biotechnology research and development of cancer therapeutics, employing its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs, including ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase.

Who are ArQule's competitors?

ArQule's competitors and similar companies include Bellwether Bio, Incyclix Bio, Imago BioSciences, Acetylon, and Theraclone Sciences.

Where is ArQule headquartered?

ArQule is headquartered in United States.

How many employees does ArQule have?

ArQule has 1,000 employees 🔒.

When was ArQule founded?

ArQule was founded in 2010 🔒.

What sector and industry vertical is ArQule in?

ArQule is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ArQule

Who are the top strategic acquirers in ArQule's sector and industry

Top strategic M&A buyers and acquirers in ArQule's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ArQule?

Top strategic M&A buyers groups and sectors for ArQule include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ArQule's sector and industry vertical

Which are the top PE firms investing in ArQule's sector and industry vertical?

Top PE firms investing in ArQule's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ArQule's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ArQule's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ArQule's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ArQule include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ArQule's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ArQule?

The key public trading comparables and valuation benchmarks for ArQule include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ArQule for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ArQule with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ArQule's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ArQule with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ArQule's' sector and industry vertical?

Access recent funding rounds and capital raises in ArQule's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ArQule